Bausch + Lomb Corporation
CA$27.99-CA$0.76 (-2.64%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.85% below the high.
CNQ · MOJO.CN · CAD
Stock price, earnings
Quote as of Jul 23, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Mojave Brands Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Mojave Brands Inc. presently conducts no substantial business activities. In the past, the company focused on the production, processing, and retail of cannabis extracts. Originally incorporated in 2010 as Mojave Jane Brands Inc., the organization rebranded to its current name, Mojave Brands Inc., in March 2020. Its primary operations are situated in Vancouver, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:08 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$27.99-CA$0.76 (-2.64%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.85% below the high.
CA$33.46-CA$0.21 (-0.62%)
Apotex Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 16.72% below the high.
$12.04-$1.04 (-7.98%)
AbCellera Biologics Inc.’s quoted price sits in the upper half of its reported 52-week range, 19.87% below the high.
CA$0.05CA$0.00 (0.0%)
PharmaCielo Ltd.’s quoted price sits in the lower half of its reported 52-week range, 69.7% below the high.
CA$0.03CA$0.00 (0.0%)
VIVO Cannabis Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
CA$0.02+CA$0.01 (+33.33%)
Aleafia Health Inc.’s quoted price sits in the lower half of its reported 52-week range, 77.78% below the high.
CA$0.09CA$0.00 (0.0%)
Telecure Technologies Inc.: Healthcare · Medical - Healthcare Information Services.
CA$0.51-CA$0.01 (-1.92%)
Sweet Earth Holdings Corporation’s quoted price sits in the upper half of its reported 52-week range, 31.08% below the high.